In-depth Immunological Investigation of COVID-19.

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Mar 26, 2020

Keywords

ClinConnect Summary

The COntAGIouS trial is a research study aimed at understanding how our immune system responds to the coronavirus that causes COVID-19. Researchers want to find out why some people become very sick from the virus while others do not. By studying patients who are hospitalized with confirmed COVID-19, they hope to discover important factors that make some individuals more vulnerable to severe illness. This information could help develop better treatments and ways to protect those at higher risk.

To take part in this study, participants need to be at least 18 years old and currently hospitalized with a confirmed case of COVID-19. Unfortunately, younger individuals or those unable to give informed consent cannot join the study. If eligible, participants can expect to provide samples for testing and answer some questions about their health. This research is important because it could lead to new insights that improve care for people with COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients \>/= 18 years old AND
• • Hospitalised with PCR-confirmed and/or CT-confirmed SARS-CoV-2 disease
• Exclusion Criteria:
• • Age \< 18 years old
• • No informed consent